Hydroquinone, Homosalate, Octisalate, Zinc Oxide

FDA Drug Profile — Obagi Nu-Derm System Normal-Oily Skin Transformation Trial, Obagi Nu-Derm System Normal-Dry Skin Transformation Kit

Hydroquinone, Homosalate, Octisalate, Zinc Oxide is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Obagi Nu-Derm System Normal-Oily Skin Transformation Trial, Obagi Nu-Derm System Normal-Dry Skin Transformation Kit. Available dosage form: kit.

Drug details

Generic Name
Hydroquinone, Homosalate, Octisalate, Zinc Oxide
Brand Names
Obagi Nu-Derm System Normal-Oily Skin Transformation Trial, Obagi Nu-Derm System Normal-Dry Skin Transformation Kit
Sponsor
Obagi Cosmeceuticals LLC
NDC Codes
2
Dosage Forms
KIT

Indications and Usage

Uses helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

Warnings For external use only Do not use on damaged or broken skin Stop use and ask a doctor if rash occurs When using this product keep out of eyes. Rinse with water to remove. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.